ITGB2 and neutropenia: Clark [135] and his colleagues developed a murine monoclonal antibody to rat Mac‐1 (1‐B6) or anti‐Mac‐1F(ab)2′ fragment, which demonstrated significant reductions in post‐traumatic neutrophil accumulation in the CNS without causing systemic neutropenia.